BWAYBrainsWay Ltd.

BWAY Stock Price, Valuation & Chart | BrainsWay Ltd.

Compare

$14.280+0.01 (+0.07%)

At close · 02 Sept 2026, 08:00 pm

Sector: Healthcare Industry: Medical - Devices BWAY intrinsic value BWAY calculated fair value vs price

Overview Financials Dividends Ratios

BWAY Historical price chart

BWAY Key Stats

Fair Value

Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock

Market Capitalization560.10M

PE Ratio36.28

EPS0.39

Trading Volume86.36K

Today's High/Low14.78/14.08

Dividend Yield0.00

52 Week High/Low17.4/7.13

Shares Outstanding39.22M

BWAY Financial Statement

BWAY Analyst ratings

BWAY Analysis & performance metrics

BWAY Company profile

Brainsway Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, Europe, Israel, and internationally. It offers…

Brainsway Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, Europe, Israel, and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic…

BWAY Management team

Name

Position

Abraham Zangen Ph.D.CTO

Co-Founder, Member of Scientific Advisory Board & Director

Yiftach Roth Ph.D.

Founder & Chief Scientific Officer

Avner HagaiCTO

Founder & Director

Ido MaromCFO

Chief Financial Officer

Dor Hagai

Vice President of Operations

David Zacut M.D.

Co-Founder & Vice-Chairman

Michael Cohen

Vice President of US Sales

Gilead Moiseyev Ph.D.CTO

Chief Technology Officer

Name

Position

Abraham Zangen Ph.D.CTO

Co-Founder, Member of Scientific Advisory Board & Director

Yiftach Roth Ph.D.

Founder & Chief Scientific Officer

Avner HagaiCTO

Founder & Director

Ido MaromCFO

Chief Financial Officer

Dor Hagai

Vice President of Operations

David Zacut M.D.

Co-Founder & Vice-Chairman

Michael Cohen

Vice President of US Sales

Gilead Moiseyev Ph.D.CTO

Chief Technology Officer

Management Team

Abraham Zangen Ph.D.CTO

Co-Founder, Member of Scientific Advisory Board & Director

Yiftach Roth Ph.D.

Founder & Chief Scientific Officer

Avner HagaiCTO

Founder & Director

Ido MaromCFO

Chief Financial Officer

Dor Hagai

Vice President of Operations

David Zacut M.D.

Co-Founder & Vice-Chairman

Michael Cohen

Vice President of US Sales

Gilead Moiseyev Ph.D.CTO

Chief Technology Officer

Management

Abraham Zangen Ph.D.CTO

Co-Founder, Member of Scientific Advisory Board & Director

Yiftach Roth Ph.D.

Founder & Chief Scientific Officer

Avner HagaiCTO

Founder & Director

Ido MaromCFO

Chief Financial Officer

Dor Hagai

Vice President of Operations

David Zacut M.D.

Co-Founder & Vice-Chairman

Michael Cohen

Vice President of US Sales

Gilead Moiseyev Ph.D.CTO

Chief Technology Officer

Total 8 executives

BWAY Frequently asked questions

What is BrainsWay Ltd. (BWAY) Stock Price?

Current stock price of BrainsWay Ltd. (BWAY) stock is $14.280. The stock price is +0.07% higher in the session. The intraday range can be seen from this page. Volume of BrainsWay Ltd. (BWAY) stock is 86.36K.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the BrainsWay Ltd. (BWAY) stock price going up or down today?

The stock price of BrainsWay Ltd. (BWAY) can change with earnings, company news, and overall market sentiment. BrainsWay Ltd. operates in the Healthcare / Medical - Devices market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the BrainsWay Ltd. stock expensive at its current price?

Whether BrainsWay Ltd. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for BWAY on this page is 36.28. EPS on this page is 0.39. Compare those figures with peers and growth expectations before deciding if the current BrainsWay Ltd. price is justified.

How has the stock price of BrainsWay Ltd. (BWAY) performed historically?

Historical performance for BrainsWay Ltd. (BWAY) is shown on the price chart on this page. Review multi-period moves alongside volume to see how BWAY reacted to past earnings and market events.

Should I buy BrainsWay Ltd. (BWAY) stock, at this price?

Buying BrainsWay Ltd. (BWAY) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.